Mirae Asset Global ETFs Holdings’s Integra LifeSciences IART Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$296K	Buy	31,447 +278	+0.9%	+$3.05K	﹤0.01%	2160
2025 Q4	$387K	Sell	31,169 -287	-0.9%	-$3.82K	﹤0.01%	2023
2025 Q3	$451K	Sell	31,456 -5,291	-14%	-$72.5K	﹤0.01%	1907
2025 Q2	$451K	Sell	36,747 -3,694	-9%	-$53.6K	﹤0.01%	1868
2025 Q1	$889K	Buy	40,441 +1,975	+5%	+$46.4K	﹤0.01%	1559
2024 Q4	$872K	Buy	38,466 +1,437	+4%	+$31.4K	﹤0.01%	1618
2024 Q3	$673K	Buy	+37,029	New	+$858K	﹤0.01%	1762

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's IART Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Integra LifeSciences (IART) stake by 0.89% in Q1 2026, buying an estimated $3.05K and bringing the position to 31,447 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #2160.

Mirae Asset Global ETFs Holdings first reported a position in IART in Q3 2024 and has held it in 7 quarters since. The position peaked at $889K in Q1 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Mirae Asset Global ETFs Holdings held 31,447 shares of Integra LifeSciences worth $296K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 278 Integra LifeSciences shares in Q1 2026, an estimated $3.05K.
Integra LifeSciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2160 holding.
Mirae Asset Global ETFs Holdings first reported a position in Integra LifeSciences in Q3 2024 and has held it in 7 quarters since.
Mirae Asset Global ETFs Holdings's Integra LifeSciences position peaked at $889K in Q1 2025.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.